Complejo Hospitalario Universitario de Badajoz
- Address
- Calle La Violeta, 3, 06010 Badajoz, Spain
Cardiovascular Diseases
At the Complejo Hospitalario Universitario de Badajoz, the pediatric department is evaluating new approaches to treat Acute Ischemic Stroke in patients with tandem lesions, focusing on the balance between clot‑reopening prevention and bleeding risk.
- Comparison of antiplatelet agents
- Assessment of reocclusion rates
- Safety monitoring for hemorrhagic transformation
The goal is to identify safer and more effective therapeutic options that could improve recovery and reduce complications after stroke.
Virus Diseases
Research in the same site’s pediatric unit also addresses respiratory viral threats by testing the safety and immune response of novel mRNA candidates, including mRNA-1345 and mRNA-1365, in infants with Acute lower respiratory infection.
- Evaluation of vaccine tolerability
- Immunogenicity profiling in young children
- Monitoring of reactogenicity signs
These investigations aim to support the development of next‑generation vaccines that protect the most vulnerable age groups from severe viral illnesses.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Complejo Hospitalario Universitario de Badajoz
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 1, Randomized, Observer-blind, Placebo-controlled, Age De-escalation Study of the Safety, Tolerability, and Immunogenicity of mRNA-1345 and mRNA-1365 in Participants Aged 5 months to < 24 months | Moderna Inc. | Phase I | Not Recruiting | May 2024 | Dec 2024 |
IMP list
lock Showing 1 of 10 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | 2022-05-01 | 2022-05-01 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.